Back

Fluoroless pulsed field ablation for the treatment of atrial fibrillation

31 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Catheter ablation in atrial fibrillation (3) Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Dalma Torma

Heart Institute, University of Pecs, Pecs (Hungary)

6 More presentations in this session

Presentation thumbnail
Prognostic value of epicardial adipose tissue parameters assessed by computed tomography in predicting atrial fibrillation ablation efficacy
Doctor K. Momot (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Predictors of atrial fibrillation recurrence after radiofrequency pulmonary vein isolation: metabolic syndrome, epicardial fat thickness, what else?
Assistant Professor E. Zaslavskaya (Saint Petersburg, RU)
Abstract Slides Video
Presentation thumbnail
Posterior wall shape as a marker for identifying candidates for posterior wall isolation in persistent atrial fibrillation
Doctor A. Sharp (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Extent of myocardial injury after pulmonary vein isolation using three different pulsed-field ablation systems
Mr J. Bruegger (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Unipolar low-voltage in the left atrium, predictors and clinical significance in patients undergoing atrial fibrillation ablation
Doctor M. Kiliszek (Warsaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Catheter ablation in atrial fibrillation (3)

The Event

Event poster

ESC Congress 2025

31 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Zero-fluoroscopy catheter ablation of atrial fibrillation using pulsed field ablation
thumbnail
Congress Presentation
Fluoroscopy-free atrial fibrillation ablation using pulsed field ablation system
thumbnail
Congress Presentation
Safety and feasibility of zero-fluoroscopy technique in ablation-index guided pulmonary vein isolation: a prospective, single center trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources